U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
197461197461A Randomized, Multicenter, Double-Blind, Parallel-Group, Placebo-Controlled Trial of the Efficacy and Safety of Bovine Anti-Cryptosporidium Immunoglobulin (BACI) in the Treatment of Cryptosporidium Enteritis in AIDS PatientsCompletedNo Results AvailableCryptosporidiosis|HIV InfectionsDrug: Cryptosporidium Immune Whey Protein Concentrate (Bovine)https://ClinicalTrials.gov/show/NCT00002248
197462197462A Randomized Study Comparing the Safety and Efficacy of Two Regimens of Oral Ganciclovir to Intravenous Ganciclovir Maintenance Therapy for Cytomegalovirus Retinitis in People With AIDS Who Have Received Prior Ganciclovir TherapyCompletedNo Results AvailableCytomegalovirus Retinitis|HIV InfectionsDrug: Ganciclovirhttps://ClinicalTrials.gov/show/NCT00002247
197463197463A Study to Evaluate the Use of Stavudine (d4T) to Treat AIDS Dementia ComplexCompletedNo Results AvailableAIDS Dementia Complex|HIV InfectionsDrug: Stavudinehttps://ClinicalTrials.gov/show/NCT00002246
197464197464A Study of the Effects of Amprenavir, a Protease Inhibitor, on Carbohydrate and Fat Metabolism in HIV-Infected PatientsCompletedNo Results AvailableHIV InfectionsDrug: Abacavir sulfate|Drug: Amprenavir|Drug: Lamivudinehttps://ClinicalTrials.gov/show/NCT00002245
197465197465A Study to Evaluate the Safety and Effectiveness of WF10 Given to Patients With Late-Stage HIV DiseaseCompletedNo Results AvailableHIV InfectionsDrug: WF10https://ClinicalTrials.gov/show/NCT00002244
197466197466A Study to Evaluate the Safety and Effectiveness of a New Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), (+)-Calanolide A, in HIV-Positive Patients Who Have Never Received Anti-HIV TreatmentCompletedNo Results AvailableHIV InfectionsDrug: Calanolide Ahttps://ClinicalTrials.gov/show/NCT00002243
197467197467Safety and Effectiveness of an Anti-HIV Drug Combination Taken Twice DailyActive, not recruitingNo Results AvailableHIV InfectionsDrug: Indinavir sulfate|Drug: Ritonavir|Drug: Lamivudine|Drug: Stavudinehttps://ClinicalTrials.gov/show/NCT00002241
197468197468Study of a New Protease Inhibitor, BMS-232632, in Combination With Other Anti-HIV DrugsCompletedNo Results AvailableHIV InfectionsDrug: Atazanavir|Drug: Nelfinavir mesylate|Drug: Stavudine|Drug: Didanosinehttps://ClinicalTrials.gov/show/NCT00002240
197469197469A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected AdultsCompletedNo Results AvailableHIV InfectionsDrug: Enfuvirtide|Drug: Ritonavir|Drug: Abacavir sulfate|Drug: Amprenavir|Drug: Efavirenzhttps://ClinicalTrials.gov/show/NCT00002239
197470197470Phase III Randomized Double-Blind Placebo Controlled Study To Evaluate the Safety and Efficacy of Betaseron in AIDS and Advanced ARC Patients Receiving a Reduced-Dose AZT RegimenCompletedNo Results AvailableHIV InfectionsDrug: Interferon beta-1b|Drug: Zidovudinehttps://ClinicalTrials.gov/show/NCT00002238
197471197471A Study of Peldesine (BCX-34) in HIV-Infected PatientsCompletedNo Results AvailableHIV InfectionsDrug: Peldesinehttps://ClinicalTrials.gov/show/NCT00002237
197472197472A Study to Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive PatientsCompletedNo Results AvailableHIV InfectionsDrug: Indinavir sulfate|Drug: Delavirdine mesylate|Drug: Zidovudinehttps://ClinicalTrials.gov/show/NCT00002236
197473197473A Study on the Safety and Effectiveness of Twice-Daily Nelfinavir Plus Twice-Daily Indinavir Plus Efavirenz in HIV-Positive Patients Who Have Never Taken Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) or Protease InhibitorsCompletedNo Results AvailableHIV InfectionsDrug: Indinavir sulfate|Drug: Nelfinavir mesylate|Drug: Efavirenzhttps://ClinicalTrials.gov/show/NCT00002235
197474197474Safety and Effectiveness of Giving an Anti-HIV Drug Combination of Adefovir Dipivoxil Plus Didanosine Plus Efavirenz Plus Lamivudine Once Daily to HIV-Infected PatientsCompletedNo Results AvailableHIV InfectionsDrug: Efavirenz|Drug: Adefovir dipivoxil|Drug: Lamivudine|Drug: Didanosinehttps://ClinicalTrials.gov/show/NCT00002234
197475197475A Study of a Combination of Four Drugs in Patients With Recent HIV InfectionCompletedNo Results AvailableHIV InfectionsDrug: Indinavir sulfate|Drug: Abacavir sulfate|Drug: Amprenavir|Drug: Lamivudinehttps://ClinicalTrials.gov/show/NCT00002233
197476197476A Study of GENEVAX-HIV, a Possible VaccineCompletedNo Results AvailableHIV Infections|HIV SeronegativityBiological: APL 400-003https://ClinicalTrials.gov/show/NCT00002232
197477197477Safety and Effects of Giving a New HIV Vaccine (GENEVAX-HIV) to HIV-Negative VolunteersCompletedNo Results AvailableHIV Infections|HIV SeronegativityBiological: APL 400-003https://ClinicalTrials.gov/show/NCT00002231
197478197478A Randomized, Placebo-Controlled Study of the Safety and Efficacy of Efavirenz, Didanosine, and Stavudine in Combination With or Without Hydroxyurea in Antiretroviral Naive or Experienced HIV-Infected PatientsCompletedNo Results AvailableHIV InfectionsDrug: Hydroxyurea|Drug: Efavirenz|Drug: Stavudine|Drug: Didanosinehttps://ClinicalTrials.gov/show/NCT00002230
197479197479Safety and Effectiveness of Adding Saquinavir (FORTOVASE) in Soft Gel Capsule Form to an Anti-HIV Drug Combination in HIV-Infected PatientsCompletedNo Results AvailableHIV InfectionsDrug: Saquinavirhttps://ClinicalTrials.gov/show/NCT00002229
197480197480A Study of T-20 in HIV-Positive AdultsCompletedNo Results AvailableHIV InfectionsDrug: Enfuvirtidehttps://ClinicalTrials.gov/show/NCT00002228
197481197481A Study of Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV DrugsCompletedNo Results AvailableHIV InfectionsDrug: Efavirenz|Drug: Lamivudine|Drug: Stavudinehttps://ClinicalTrials.gov/show/NCT00002227
197482197482Safety and Effectiveness of Giving SU5416 to HIV-Infected Patients With AIDS-Related Kaposi's SarcomaCompletedNo Results AvailableSarcoma, Kaposi|HIV InfectionsDrug: SU5416https://ClinicalTrials.gov/show/NCT00002226
197483197483A Study of Efavirenz in Combination With Stavudine and DidanosineCompletedNo Results AvailableHIV InfectionsDrug: Efavirenz|Drug: Stavudine|Drug: Didanosinehttps://ClinicalTrials.gov/show/NCT00002225
197484197484Comparison of Two Anti-HIV Regimens That Include One of Two Forms of Didanosine (ddI)CompletedNo Results AvailableHIV InfectionsDrug: Nelfinavir mesylate|Drug: Stavudine|Drug: Didanosinehttps://ClinicalTrials.gov/show/NCT00002224
197485197485A Study of Ritonavir/Indinavir Combination in HIV-Infected PatientsCompletedNo Results AvailableHIV InfectionsDrug: Indinavir sulfate|Drug: Ritonavirhttps://ClinicalTrials.gov/show/NCT00002223
197486197486A Study of Valganciclovir in the Treatment of Cytomegalovirus (CMV) Retinitis in Patients With AIDSCompletedNo Results AvailableCytomegalovirus Retinitis|HIV InfectionsDrug: Valganciclovirhttps://ClinicalTrials.gov/show/NCT00002222
197487197487Gene Therapy in HIV-Positive Patients With Non-Hodgkin's LymphomaCompletedNo Results AvailableLymphoma, Non-Hodgkin|HIV InfectionsDrug: Peripheral blood stem cellshttps://ClinicalTrials.gov/show/NCT00002221
197488197488Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success With NelfinavirCompletedNo Results AvailableHIV InfectionsDrug: Indinavir sulfate|Drug: Efavirenz|Drug: Levocarnitine|Drug: Adefovir dipivoxilhttps://ClinicalTrials.gov/show/NCT00002220
197489197489Safety and Effectiveness of Adding Adefovir Dipivoxil and Nelfinavir to the Anti-HIV Therapy of HIV-Infected ChildrenActive, not recruitingNo Results AvailableHIV InfectionsDrug: Nelfinavir mesylate|Drug: Levocarnitine|Drug: Adefovir dipivoxilhttps://ClinicalTrials.gov/show/NCT00002219
197490197490A Phase I Maximum Tolerated Dose Study of CI-1012 in Late-Stage HIV+ PatientsCompletedNo Results AvailableHIV InfectionsDrug: CI-1012https://ClinicalTrials.gov/show/NCT00002218

* Görseller ve İçerik tekif hakkına sahip olabilir